Creativity, artificial intelligence, and the requirement of human authors and inventors in copyright and patent law by Mammen, CE, Collyer, M, Dolin, R, Gangjee, DS, Melham, T, Mustaklem, M, Sundaralingam, P, Wang-Maścianica, V

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine by Walsh SR, Seaman MS, Johnson JA, Tucker RP, Krause KH, Weijtens M, Pau MG, Goudsmit J, Dolin R, Barouch DH, Baden LR